Inclusion Criteria:  any stage of cancer, with a confirmed treatment plan consisting of taxane-based or oxaliplatin-based chemotherapy, neuropathic pain and/or peripheral sensory neuropathy with VAS score ≥ 3 that are resistant to medical treatment  Exclusion Criteria:  patients with intracranial metallic devices or with pacemakers or any other device. - -W those with extensive myocardial ischemia, higher brain dysfunction, migraine headache, brain cancer or metastasis and those known to have epilepsy